Elevai Skincare, an Elevai Labs Subsidiary, Reports Encouraging Hair Restoration Data Results

September 3, 2024

DENVER, Colo., Sep 03, 2024 (247marketnews.com)- Elevai Labs (NASDAQ: ELAB) shared data from an on-going research study that assessed the application of topical Elevai exosomes, in clinic and at home, on participants experiencing hair loss or hair thinning, conducted in partnership with Carly Klein, President of the National Hair Loss Medical Aesthetics (“NHLMA”), which demonstrated the potential of its proprietary Elevai Exosomes in hair restoration.

Klein stated, “We tested patients with androgenetic alopecia, delivering Elevai’s unique age zero exosomes to the scalp focusing on areas of thinning.

“These exosomes were utilized in the early and late stages of hair loss, and we saw promising results, giving us confidence that this technology can be used successfully in combination with other hair restoration approaches.”

The research study results were assessed using imaging analysis up to 12 months, showing ceased crown inflammation, reversal of miniaturized hairs and recovered hair from the dormant phase, among other benefits.

Dr. Jordan R. Plews, PhD, Elevai Skincare’s CEO, commented, “NHLMA’s findings provide the initial validation of our exosome technology on hair and scalp health.

“We are in the process of conducting a follow-on study with the combination of Elevai exosomes and Yuva’s Y100 mitochondrial technology to address common scalp and hair care concerns, such as the appearance of thinning hair, by promoting scalp and hair vitality.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (ELAB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.